The use of complementary and alternative medicine by patients with cancer: a cross-sectional survey in Saudi Arabia KA Abuelgasim, Y Alsharhan, T Alenzi, A Alhazzani, YZ Ali, AR Jazieh BMC Complementary and Alternative Medicine 18, 1-8, 2018 | 102 | 2018 |
Decreased serum glucose and glycosylated hemoglobin levels in patients with Chuvash polycythemia: a role for HIF in glucose metabolism DA McClain, KA Abuelgasim, M Nouraie, J Salomon-Andonie, X Niu, ... Journal of molecular medicine 91, 59-67, 2013 | 56 | 2013 |
Depression and anxiety in patients with hematological malignancies, prevalence, and associated factors KA Abuelgasim, GY Ahmed, JA Alqahtani, AM Alayed, AS Alaskar, ... Saudi medical journal 37 (8), 877, 2016 | 38 | 2016 |
Highlights of the management of adult histiocytic disorders: Langerhans cell histiocytosis, Erdheim-Chester disease, Rosai-Dorfman disease, and hemophagocytic lymphohistiocytosis HA Salama, AR Jazieh, AY Alhejazi, A Absi, S Alshieban, M Alzahrani, ... Clinical Lymphoma Myeloma and Leukemia 21 (1), e66-e75, 2021 | 34 | 2021 |
The trends of complementary alternative medicine use among cancer patients AR Jazieh, KA Abuelgasim, HI Ardah, M Alkaiyat, OB Da’ar BMC Complementary Medicine and Therapies 21 (1), 167, 2021 | 20 | 2021 |
Chemoimmunotherapy with brentuximab vedotin combined with ifosfamide, gemcitabine, and vinorelbine is highly active in relapsed or refractory classical Hodgkin lymphoma KA Abuelgasim, M Alzahrani, Y Alsharhan, M Khairi, M Hommady, ... Bone Marrow Transplantation 54 (7), 1168-1172, 2019 | 19 | 2019 |
Reactivation of tuberculosis following ruxolitinib therapy for primary myelofibrosis: case series and literature review F Khalid, M Damlaj, M AlZahrani, KA Abuelgasim, GE Gmati Hematology/Oncology and Stem Cell Therapy 14 (3), 252-256, 2021 | 17 | 2021 |
Impact of age and induction therapy on outcome of 180 adult patients with acute myeloid leukemia; retrospective analysis and literature review KA Abuelgasim, B Albuhayri, R Munshi, A Al Mugairi, B Alahmari, G Gmati, ... Leukemia Research Reports 14, 100206, 2020 | 15 | 2020 |
Pre-autologous transplantation PET/CT using Deauville criteria is an independent predictor of progression in relapsed refractory classical Hodgkin lymphoma M Damlaj, S Ghazi, G Syed, T Pasha, G Gmati, H Salama, O Ali, ... Bone marrow transplantation 52 (9), 1342-1344, 2017 | 14 | 2017 |
Coexistence of chronic myeloid leukemia and diffuse large B-cell lymphoma with antecedent chronic lymphocytic leukemia: a case report and review of the literature KA Abuelgasim, H Rehan, M Alsubaie, N Al Atwi, M Al Balwi, S Alshieban, ... Journal of Medical Case Reports 12, 1-8, 2018 | 12 | 2018 |
An atypical initial presentation of chronic myeloid leukemia with central nervous system and lymph node blast crises KA Abuelgasim, S Alshieban, NA Almubayi, A Alhejazi, AR Jazieh Case Reports in Oncology 9 (2), 415-421, 2016 | 10 | 2016 |
Electronic early notification of sepsis in hospitalized ward patients: a study protocol for a stepped-wedge cluster randomized controlled trial YM Arabi, A Alsaawi, M Al Zahrani, AM Al Khathaami, RH AlHazme, ... Trials 22, 1-12, 2021 | 9 | 2021 |
Incidence and predictors of recurrence and mortality following first venous thromboembolism among the Saudi population: single-center cohort study FAS AlEidan, RK AlManea, AT AlMoneef, NA Shalash, NA AlRajhi, ... International Journal of General Medicine 15, 7559, 2022 | 7 | 2022 |
Impact of cluster of differentiation 20 expression and rituximab therapy in classical Hodgkin lymphoma: Real world experience KA Abuelgasim, R Al Shammari, S Alshieban, B Alahmari, M Alzahrani, ... Leukemia Research Reports 15, 100240, 2021 | 7 | 2021 |
Outcome of age-adapted approach to HLA-identical related hematopoietic stem cell transplantation in severe sickle cell disease: Saudi experience M Alzahrani, M Damlaj, M Essa, B Alahmari, A Alaskar, A Hejazi, ... Blood 132, 3468, 2018 | 6 | 2018 |
Venetoclax in combination with carfilzomib and dexamethasone in relapsed/refractory multiple myeloma harboring t (11, 14)(q13; q32): two case reports and a review of the literature KA Abuelgasim, N Alherz, A Alhejazi, M Damlaj Journal of Medical Case Reports 14, 1-6, 2020 | 5 | 2020 |
The trends of cancer patients’ perceptions on the causes and risk factors of cancer over time AR Jazieh, M Alkaiyat, KA Abuelgasim, H Ardah Saudi Medical Journal 43 (5), 479, 2022 | 4 | 2022 |
Isolated Bone Marrow Non–Langerhans Cell Histiocytosis Preceding RUNX1-Mutated Acute Myeloid Leukemia: Case Report and Literature Review A Al Mugairi, S Al Turki, H Salama, K Al Ahmadi, KA Abuelgasim, ... American Journal of Clinical Pathology 151 (6), 638-646, 2019 | 4 | 2019 |
Method of treating leukemia based on gene expression of clock genes M Boudjelal, A Al Askar, A Alhallaj, A Nehdi, H Rehan, S Rahman, ... US Patent 10,253,371, 2019 | 4 | 2019 |
A Drug Repositioning Approach Identifies a Combination of Compounds as a Potential Regimen for Chronic Lymphocytic Leukemia Treatment A Nehdi, N Samman, A Mashhour, A Alhallaj, T Trivilegio, S Gul, ... Frontiers in Oncology 11, 579488, 2021 | 3 | 2021 |